- Home
- CLGN vs PPCB Comparison
CLGN vs PPCB Comparison
Compare CLGN & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- PPCB
- Stock Information
- Founded
- CLGN 2004
- PPCB 2007
- Country
- CLGN Israel
- PPCB Australia
- Employees
- CLGN N/A
- PPCB N/A
- Industry
- CLGN Industrial Specialties
- PPCB
- Sector
- CLGN Health Care
- PPCB
- Exchange
- CLGN Nasdaq
- PPCB Nasdaq
- Market Cap
- CLGN 33.8M
- PPCB 39.1M
- IPO Year
- CLGN N/A
- PPCB N/A
- Fundamental
- Price
- CLGN $2.62
- PPCB $2.02
- Analyst Decision
- CLGN Strong Buy
- PPCB
- Analyst Count
- CLGN 2
- PPCB 0
- Target Price
- CLGN $11.50
- PPCB N/A
- AVG Volume (30 Days)
- CLGN 37.8K
- PPCB 5.2M
- Earning Date
- CLGN 08-20-2025
- PPCB 09-30-2025
- Dividend Yield
- CLGN N/A
- PPCB N/A
- EPS Growth
- CLGN N/A
- PPCB N/A
- EPS
- CLGN N/A
- PPCB N/A
- Revenue
- CLGN $2,402,000.00
- PPCB N/A
- Revenue This Year
- CLGN $1,999.42
- PPCB N/A
- Revenue Next Year
- CLGN $69.81
- PPCB N/A
- P/E Ratio
- CLGN N/A
- PPCB N/A
- Revenue Growth
- CLGN 248.62
- PPCB N/A
- 52 Week Low
- CLGN $1.31
- PPCB $0.00
- 52 Week High
- CLGN $5.45
- PPCB $145.46
- Technical
- Relative Strength Index (RSI)
- CLGN 52.28
- PPCB N/A
- Support Level
- CLGN $2.56
- PPCB N/A
- Resistance Level
- CLGN $2.87
- PPCB N/A
- Average True Range (ATR)
- CLGN 0.25
- PPCB 0.00
- MACD
- CLGN -0.02
- PPCB 0.00
- Stochastic Oscillator
- CLGN 68.01
- PPCB 0.00
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About PPCB Propanc Biopharma Inc.
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.